As of June 30, 2026, Aurora Labs Ltd. carries a market capitalization of 26.70M, placing it among publicly traded companies globally. Its enterprise value stands at 24.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 26.70M |
| Enterprise Value | 24.82M |
As of June 30, 2026, Aurora Labs Ltd. has 523.62M shares outstanding.
| Shares Outstanding | 523.62M |
These figures are as of June 30, 2026. The price-to-sales ratio is 43.25, and the price-to-book ratio stands at 10.81.
| PS Ratio | 43.25 |
| PB Ratio | 10.81 |
| P/TBV Ratio | 10.81 |
These figures are as of June 30, 2026. The EV/Sales ratio of 43.99 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 24.82M versus a market cap of 26.70M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 43.99 |
As of June 30, 2026, Aurora Labs Ltd. maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.04, indicating elevated leverage, while an interest coverage ratio of -133.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.23 |
| Quick Ratio | 1.17 |
| Debt / Equity | 4.04 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | -133.68 |
Over the twelve months ended June 30, 2026, Aurora Labs Ltd. posted a negative return on equity (ROE) of -288.53, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -130.63, reflecting losses generated across the asset base. The company generates approximately 31,345.44 in revenue per employee across its workforce of 18.00, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -288.53 |
| Return on Assets (ROA) | -130.63 |
| Revenue Per Employee | 31,345.44 |
| Employee Count | 18.00 |
As of the close on November 17, 2026, Aurora Labs Ltd.'s stock has gained approximately 20.83% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.05.
| 52-Week Price Change | 20.83% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.05 |
Over the twelve months ended June 30, 2026, Aurora Labs Ltd. generated 564,218.00 in revenue and converted that into -5.11M in net income, yielding earnings per share of -0.01. EBITDA reached -5.67M, while operating income came in at -5.91M.
| Revenue | 564,218.00 |
| Gross Profit | 522,218.00 |
| Operating Income | -5.91M |
| Pretax Income | -5.11M |
| Net Income | -5.11M |
| EBITDA | -5.67M |
| EBIT | -5.92M |
| Earnings Per Share (EPS) | -0.01 |
As of June 30, 2026, Aurora Labs Ltd. holds 1.98M in cash and equivalents against 99,736.00 in total debt, resulting in a net debt position of -1.98M. Total book value stands at 2.47M, with working capital of 572,704.00 providing operational flexibility.
| Cash & Cash Equivalents | 1.98M |
| Total Debt | 99,736.00 |
| Net Debt | -1.98M |
| Equity (Book Value) | 2.47M |
| Working Capital | 572,704.00 |
These figures cover the twelve months ended June 30, 2026.
| Capital Expenditures | -1.15M |
Over the twelve months ended June 30, 2026, Aurora Labs Ltd. posted a gross margin of 92.56, reflecting its pricing power and cost economics. The operating margin of -1,048.12 and net profit margin of -905.78 provide insight into operational efficiency.
| Gross Margin | 92.56 |
| Operating Margin | -1,048.12 |
| Pretax Margin | -905.78 |
| Profit Margin | -905.78 |
| EBITDA Margin | -1,004.99 |
These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -18.65, meaning Aurora Labs Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -18.65 |
As of June 30, 2026, Aurora Labs Ltd. has an Altman Z-Score of -10.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.06 |
Already premium?